Resources

Smoke and Mirrors: The Marketing Traps in Full-Body MRI

Back to Resources
Download PDF

Author: Dr Kirralee Sherif (PhD Eng)

Full-body MRI has garnered significant attention as a powerful tool for early disease detection, particularly in oncology and cancer staging [1]. More recently, it has been applied to cancer screening in asymptomatic patients. However, the increasing demand for its use as a screening tool has led some providers—lacking the necessary expertise for oncology-grade imaging—to market their services solely for screening. If a company cannot reliably detect known cancer cases, it is unreasonable for them to claim they can identify undiagnosed cancer. These providers exploit the inherent trust patients place in MRI, using misleading metrics to promote their screening services. Unfortunately, this can result in patients receiving “normal” scan reports—not because they are truly free of early-stage cancer or other pathology, but because the imaging was inadequate for detection. Understanding the complexities of MRI and recognising how some providers cut corners is essential for patients seeking reliable and accurate screening.

MRI is an incredibly sophisticated imaging modality, and full-body MRI is one of the most challenging scans to perform. Achieving high-quality results requires expertise, advanced equipment, and adherence to standardised protocols. Unfortunately, many providers focus on superficial metrics such as price, scan time, or magnet strength to market their services, which can be misleading for patients.

Misleading Metrics to Watch For

1. Advertising 3T Whole-Body MRI as ‘better’

The best scan is one that can detect and characterise disease at the earliest stage with the highest accuracy. While 3T MRI scanners offer twice the signal strength of 1.5T systems, most providers struggle to perform the most critical sequence—diffusion-weighted imaging (DWI)—adequately for whole body scanning at this strength.

International recommendations [2] state that for whole-body MRI at 3T, scanners should include multi-transmit technology to ensure uniform image quality. Currently, Philips is the only manufacturer with this capability. If a provider offers whole-body MRI on a 3T scanner that is not Philips, they do not meet these published recommendations. Even on a Philips 3T system, or a 1.5T the provider must still be able to correct for distortion to achieve a properly co-registered diffusion and anatomical scan.

2. Omission of Critical Sequences

One of the most essential sequences in full-body MRI for cancer screening is Diffusion-Weighted Imaging (DWI) and its advanced application, Diffusion-Weighted Whole Body Imaging with Background Signal Suppression (DWIBS). This sequence is invaluable for detecting small, early-stage malignancies.

However, some providers either perform DWI/DWIBS to an undiagnostic standard, omit it altogether or omit it in specific regions, often the neck and chest, because these areas are technically challenging to image. This substandard imaging or omission significantly compromises the diagnostic value of the scan, yet it is rarely disclosed to patients.

3. Suboptimal DWIBS Parameters

The sensitivity of DWIBS depends on many parameters that influence the contrast of diffusion-weighted images. For example, the b-value in diffusion MRI controls the sensitivity of the sequence to water diffusion by adjusting the strength and timing of the diffusion-sensitising gradients, with higher b-values emphasising restricted diffusion seen in pathological tissues like tumours or acute infarcts. A higher b-value, such as B1000, is more sensitive for detecting small lesions. Some providers perform DWIBS at a lower b-value, like B800, which reduces the scan’s ability to detect early-stage cancers. Patients are often unaware of this technical limitation. The quality of the DWI/DWIBS is crucial for full-body MRI scanning.

4. Lack of Quantitative Analysis

Quantitative MRI involves measuring specific biomarkers, such as Apparent Diffusion Coefficient (ADC) values in DWI. Quantitative analysis often involves the purchase of additional software to measure important factors such as brain segmentation and volumes (NeuroQuant/SyMRI) and performing analysis for neurodegenerative diseases, or absolute tissue properties for quantification of issues such as fatty liver. This data helps differentiate between benign and malignant lesions with greater precision or define a degree of a disease. Providers that do not include quantitative analysis limit the clinical utility of their reports, leaving radiologists and referring physicians with less actionable information.

5. Less Comprehensive Scans

Some full-body MRI providers omit critical health sequences or areas of the body to save time and reduce costs. For example, essential brain imaging sequences, crucial for detecting neurological abnormalities, may be excluded. Similarly, the lower limbs might be left out of the analysis, overlooking key findings related to musculoskeletal or systemic diseases such as synovial sarcoma which are commonly found in the knees or ankles. These omissions drastically reduce the scan’s ability to provide a complete health assessment.

Worse still, patients are often unaware of these cost-cutting exclusions, and radiologists typically report only on abnormal findings. This introduces confirmation bias: a patient may receive a report indicating no abnormalities, not because they are disease-free, but because the scan lacked sufficient data to rule out the disease comprehensively.

Furthermore, whilst full-body MRI offers unparalleled detail for most organ systems, its Achilles’ heel is the lungs. The air-filled structures and rapid motion during breathing limit MRI’s effectiveness in providing high-resolution images of lung tissue. For a truly comprehensive analysis, full-body MRI should be complemented with low dose CT chest imaging (our low dose Spectral chest CT is performed at <0.7 mSv and our hyper-low-dose chest CT is performed at <0.2 mSv), which excels in detecting lung abnormalities with exceptional clarity.

It is essential that the imaging provider fully understands the limitations of their scan and the complementary imaging required to address these gaps, ensuring this information is clearly communicated to the patient as part of the informed consent process.

6. Reduced Scan Times

Shortening scan durations is a common cost-cutting strategy that significantly impacts the reliability of full-body MRI examinations. By using fewer imaging sequences or accelerating acquisition times, the data collected is often less detailed and prone to artefacts or noise, making it harder to detect subtle abnormalities. Critical sequences that provide specific diagnostic insights, such as diffusion-weighted imaging or fat suppression, may be skipped entirely to save time. This not only increases the likelihood of missed diagnoses but also undermines the very purpose of whole-body MRI as a comprehensive screening tool. Prioritising speed over quality can result in false reassurance for patients or the need for additional follow-up imaging, negating any initial cost savings.

7. Increasing Slice Thickness

MRI images are acquired in slices, and the thickness of these slices plays a critical role in the accuracy and diagnostic quality of the scan. Thicker slices, while faster to acquire and often appearing less distorted to the untrained eye, reduce the level of detail and spatial resolution. This occurs because thicker slices average the signals from a larger volume of tissue, potentially obscuring subtle abnormalities or making it harder to distinguish between adjacent structures.

The reduced appearance of distortion in these images can be misleading, giving the false impression of superior image quality when, in fact, critical diagnostic information may be lost. This trade-off highlights the importance of understanding the relationship between slice thickness and image accuracy, as thinner slices, though potentially more prone to apparent artefacts, provide far greater precision and reliability for detecting and diagnosing medical conditions.

8. Providers Offering Whole-Body MRI “Screening” Without Possessing the Capability to Perform an Oncology “Staging”

If a provider cannot accurately stage cancer using Whole-Body MRI, then their scans are not precise enough for early disease detection. It’s simple—if a system cannot reliably detect cancer when we know it is present, how can it possibly detect cancer before it is diagnosed?

Unfortunately, in an effort to capitalise on demand, many providers are offering so-called “screening” MRIs without fully understanding or adhering to the necessary guidelines and technical requirements for a clinically robust scan. One company even admitted that they carefully phrase their documentation to say “screening MRI” rather than “cancer screening” to avoid accountability—a third-party independent radiologist’s review of this company’s scan indicated that at best they could detect “late-stage” cancer in some regions—this defeats the entire purpose. The patient has completely wasted their money rather than saving money and will possibly ignore symptoms or have a bias towards assuming wellness because they have been given a false all-clear.

Australia currently lacks dedicated Whole-Body MRI screening guidelines, meaning providers must follow internationally recognised standards and recommendations—which I have outlined in a previous blog. The bottom line? If a provider cannot stage known cancers using their MRI protocol, their scans are simply not accurate enough to detect early disease when it truly matters.

9. Absence of ONCO-RADS Ratings

ONCO-RADS (Oncological Relevant Findings and Reporting System) is a standardised framework for full-body MRI reporting, ensuring consistent and objective interpretations. Without ONCO-RADS ratings, radiology reports may lack uniformity, increasing the risk of miscommunication among healthcare providers. This scoring system plays a crucial role in managing incidental findings, and its absence can lead to unnecessary patient anxiety and additional testing.

Ignoring Patient Comfort

Undergoing an MRI scan can be an uncomfortable experience, especially for a full-body scan that takes considerable time. In-bore entertainment, such as music or videos, can significantly improve patient comfort and reduce motion artefacts caused by anxiety or restlessness. Many providers overlook this crucial aspect, making the experience unnecessarily unpleasant.

Other Misleading Marketing Metrics

Misleading marketing metrics in medical imaging, such as emphasising data acquisition rates or inflated claims about the number of abnormalities detected, can create confusion and set unrealistic expectations. For example, touting a high data acquisition rate is irrelevant if the data collected lacks diagnostic quality—acquiring poor-quality data quickly serves no one.

Similarly, claims like “scanning for over 500 abnormalities” are often misleading because they aggregate the sum of abnormalities detectable across various scan protocols (e.g., head and neck, chest and abdomen, full body), resulting in duplication of abnormalities in overlapping regions. Additionally, these counts often include an infinite number of nuanced findings that, while technically “abnormalities,” are irrelevant to whole-body screening. Extreme examples, such as identifying and including missing digits or minor non-clinical variations, highlight how these metrics can distort the value of the screening and misguide patients about its utility.

Comparing Apples with Apples

Comparing full-body MRI providers is notoriously challenging because it’s not a matter of a single metric but a complex interplay of metrics and complex physics principals that are traditionally difficult to understand by the general public that collectively determine the scan’s value. Financially, one might evaluate the “total cost to information acquired,” but this approach overlooks the critical dimension of information quality—how detailed, accurate, and actionable the results are.

Similarly, using “time” as a metric for patient comfort is highly misleading. Many providers fail to account for in-bore experience, including factors like bed comfort, noise levels, or even patient anxiety management, all of which can significantly impact the overall experience. The chain of service, from scheduling to reporting, also varies widely in efficiency and thoroughness, further complicating comparisons. While these complexities make it difficult to evaluate providers in a straightforward “apples-to-apples” manner, a deeper understanding of these metrics—and their influence on outcomes—empowers better decision-making and ensures that the focus remains on quality, comfort, and reliability, rather than just cost or convenience.

How We Do It Differently

At Whole Body MRI™, we prioritise accuracy, patient comfort, and transparency. Here’s how we stand apart:

  • DWI/DWIBS on a 3T platform with In-Plane Geometric Correction: We can uniquely perform this on a 3T platform for the whole body with complete distortion correction.
  • Advanced Quantitative Analysis: Our reports include ADC values, SyMRI, NeuroQuant®, NeuroQuant® MS, NeuroQuant® Brain Tumour and other quantitative metrics such as liver fat and iron for more accurate information.
  • Optimised DWIBS Parameters: Over 15 years of continuous development in collaboration with some of the world’s leading experts in whole-body MRI, we have developed and optimised DWIBS parameters specifically for whole-body imaging on the 3T platform—parameters that are not commercially available. Our DWIBS is set at b1000 to maximise sensitivity for cancer detection.
  • Most Comprehensive Full-Body MRI: We capture more voxels at a greater level of detail than any other commercially available full-body MRI product. We also include a low dose chest CT and a calcium score performed on a Spectral CT in all Whole Body MRI™ Scans.
  • Standardised Reporting: In compliance with RANZCR recommendations, our reports are template driven and include ONCO-RADS ratings for clear, consistent communication.
  • Patient-Centric Approach: We offer in-bore entertainment and have many other options to ensure a comfortable and stress-free experience.

This comprehensive guide details everything you need to know about preparing for your Whole Body MRI™ scan.

Conclusion

Full-body MRI is a remarkable diagnostic tool, but not all full-body MRI services are created equal. Patients should be vigilant about marketing traps that prioritise convenience or cost over quality and accuracy. At Whole Body MRI™, we are committed to delivering uncompromised diagnostic excellence, ensuring our patients receive the care they deserve.

When it comes to your health, there is no room for compromise. Explore the difference with Whole Body MRI™—Australia’s most advanced full-body MRI provider.

Visit our Frequently Asked Questions page to learn more about our scans, including preparation and benefits.

 

 

References

[1] Sai Swarupa Vulasala, Mayur Virarkar, Niloofar Karbasian, Luis F. Calimano-Ramirez, Taher Daoud, Behrang Amini, Priya Bhosale, Sanaz Javadi, Whole-body MRI in oncology: A comprehensive review, Clinical Imaging, Volume 108, 2024.

[2] Petralia G, Zugni F, Summers PE, et al. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: recommendations for use. Radiol Med. 2021;126(11):1434-1450. doi:10.1007/s11547-021-01392-2

Download PDF

Journey into the known with a Whole Body MRI™ scan